The U.S. Market for Peripheral Vascular Devices Will Worth over $6 B by 2020


Dallas, TX -- (ReleaseWire) -- 01/23/2014 -- By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion.

The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period.

Get a copy of complete report @ Also, Request a sample @

Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval.

Scope: This report pertains to a forecast period of 10 years (2010 – 2020) for the U.S.

Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment
Trend Analysis by Segment
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring

Main Segments Included:
Peripheral Vascular Stent Market
PTA Balloon Catheter Market
Atherectomy Device Market
Chronic Total Occlusion (CTO) Device Market
Embolic Protection Device Market
Stent Graft Market
Surgical Graft Market
AV Access Thrombectomy Device Market
Inferior Vena Cava Filter Market
Diagnostic and Interventional Catheter Market
Diagnostic and Interventional Guidewire Market
Introducer Sheath Market
Vascular Closure Device Market
Transcatheter Embolization Device Market
For a list of subsegments included and for more information please contact

Inquire for discount offered on this report @

Companies Included in this Report:
C. R. Bard
Abbott Laboratories
Cook Medical
W. L. Gore
Boston Scientific
St. Jude Medical
Cardiovascular Systems Inc
Atrium Medical
Argon Medical

Others include: AccessClosure, ALN International Inc., AngioDynamics, AngioScore, Angiotech, Argon Medical, Arstasis, Artegraft, Asahi Intecc USA, Inc., Atrax, B. Braun, Cardiva CeloNova Biosciences, IDEV Technologies, Inc., LeMaitre Vascular, Maquet, Marine Polymer Technologies, MEDRAD, Morris Innovative, Penumbra, Teleflex Medical, Theragenics, etc.

Place a direct purchase order @

Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.

Contact for more details.